Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673334 · ClinicalTrials.gov registry record · Phase 4
Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms
A Phase 4 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01673334 is a Phase 4 study that has completed, run by University of Virginia. The registered enrollment target is 40 participants.
The verdict
NCT01673334, a Phase 4 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
We aim to compare the efficacy (diagnostic yield), ease of use, and technical success rates of EUS guided 22 gauge fine needle aspiration to core biopsy in the evaluation of pancreatic tumors. The experimental hypothesis is that FNA will have superior overall diagnostic yield than core biopsy.
Interventions
- DEVICE Fine Needle Aspiration (FNA) and Core biopsy (FNB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-07-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01673334
The ClinicalTrials.gov registry entry for NCT01673334 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fine Needle Aspiration (FNA) and Core biopsy (FNB) is the first listed.
NCT01673334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01673334 about?
NCT01673334 is a clinical study titled "Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms". We aim to compare the efficacy (diagnostic yield), ease of use, and technical success rates of EUS guided 22 gauge fine needle aspiration to core biopsy in the evaluation of pancreatic tumors. The experimental hypothesis is that FNA will have superior overall diagnostic yield than core biopsy.
What is the current status of trial NCT01673334?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2011-09. Estimated completion is 2013-07-09.
What interventions are being tested in trial NCT01673334?
The interventions under investigation include: Fine Needle Aspiration (FNA) and Core biopsy (FNB) (DEVICE).
Who is sponsoring clinical trial NCT01673334?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.